Panlong Pharmaceutical: Director Zhu Wenfeng completes a 0.0212% share reduction

Panlong Pharmaceutical Announcement: Director Zhu Wenfeng reduced his holdings by 22,500 shares through centralized bidding on March 12, 2026, at an average price of 33.49 yuan per share, representing a 0.0212% reduction.
Before the reduction, he held 90,000 shares; after the reduction, he held 67,500 shares, accounting for 0.0637%.
The reduction plan has been fully implemented.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin